These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21544558)

  • 1. Practical implications for the administration of 13-cis retinoic acid in pediatric oncology.
    Bauters TG; Laureys G; Van de Velde V; Benoit Y; Robays H
    Int J Clin Pharm; 2011 Aug; 33(4):597-8. PubMed ID: 21544558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.
    Matthay KK; Villablanca JG; Seeger RC; Stram DO; Harris RE; Ramsay NK; Swift P; Shimada H; Black CT; Brodeur GM; Gerbing RB; Reynolds CP
    N Engl J Med; 1999 Oct; 341(16):1165-73. PubMed ID: 10519894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.
    Villablanca JG; Khan AA; Avramis VI; Seeger RC; Matthay KK; Ramsay NK; Reynolds CP
    J Clin Oncol; 1995 Apr; 13(4):894-901. PubMed ID: 7707116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.
    Reynolds CP
    Curr Oncol Rep; 2000 Nov; 2(6):511-8. PubMed ID: 11122886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma.
    Veal GJ; Errington J; Rowbotham SE; Illingworth NA; Malik G; Cole M; Daly AK; Pearson AD; Boddy AV
    Clin Cancer Res; 2013 Jan; 19(2):469-79. PubMed ID: 23087409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation.
    Khan AA; Villablanca JG; Reynolds CP; Avramis VI
    Cancer Chemother Pharmacol; 1996; 39(1-2):34-41. PubMed ID: 8995497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia and 13-cis-retinoic acid in post-consolidation therapy of neuroblastoma.
    Marabelle A; Sapin V; Rousseau R; Periquet B; Demeocq F; Kanold J
    Pediatr Blood Cancer; 2009 Feb; 52(2):280-3. PubMed ID: 18839433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted isotretinoin in neuroblastoma: kinetics, genetics, or absorption.
    Matthay KK
    Clin Cancer Res; 2013 Jan; 19(2):311-3. PubMed ID: 23209029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.
    Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CP; Kogner P
    Med Pediatr Oncol; 2001 Jan; 36(1):127-31. PubMed ID: 11464864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premature physeal closure following 13-cis-retinoic acid and prolonged fenretinide administration in neuroblastoma.
    Steineck A; MacKenzie JD; Twist CJ
    Pediatr Blood Cancer; 2016 Nov; 63(11):2050-3. PubMed ID: 27399265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acid.
    Villablanca JG; Khan AA; Avramis VI; Reynolds CP
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):410-5. PubMed ID: 8214363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical method for oral administration of isotretinoin in pediatric oncology patient: A case study of neuroblastoma.
    Alwhaibi A; Alenazi M; Almadi B; Alotaibi A; Alshehri SM; Shakeel F
    J Oncol Pharm Pract; 2023 Apr; 29(3):755-759. PubMed ID: 35912495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study.
    Shusterman S; Naranjo A; Van Ryn C; Hank JA; Parisi MT; Shulkin BL; Servaes S; London WB; Shimada H; Gan J; Gillies SD; Maris JM; Park JR; Sondel PM
    Clin Cancer Res; 2019 Oct; 25(20):6044-6051. PubMed ID: 31358541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy.
    Kohler JA; Imeson J; Ellershaw C; Lie SO
    Br J Cancer; 2000 Nov; 83(9):1124-7. PubMed ID: 11027423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalcemia and osteoblastic lesions induced by 13-Cis-retinoic acid mimicking relapsed neuroblastoma.
    Cross SF; Dalla Pozza L; Munns CF
    Pediatr Blood Cancer; 2009 Oct; 53(4):666-8. PubMed ID: 19492317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of growth failure caused by 13-CIS-retinoic acid administration after bone marrow transplantation for neuroblasoma.
    Inamo Y; Suzuki T; Mugishima H
    Endocr J; 1999 Mar; 46 Suppl():S113-5. PubMed ID: 12054112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting, Monitoring, and Managing Hypercalcemia Secondary to 13-Cis-Retinoic Acid Therapy in Children With High-risk Neuroblastoma.
    Chen SC; Murphy D; Sastry J; Shaikh MG
    J Pediatr Hematol Oncol; 2015 Aug; 37(6):477-81. PubMed ID: 26056798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group.
    Finklestein JZ; Krailo MD; Lenarsky C; Ladisch S; Blair GK; Reynolds CP; Sitarz AL; Hammond GD
    Med Pediatr Oncol; 1992; 20(4):307-11. PubMed ID: 1608352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bottom up proteomics reveals novel differentiation proteins in neuroblastoma cells treated with 13-cis retinoic acid.
    Halakos EG; Connell AJ; Glazewski L; Wei S; Mason RW
    J Proteomics; 2019 Oct; 209():103491. PubMed ID: 31472280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercalcemia induced by 13-cis-retinoic acid in a patient with neuroblastoma.
    Belden TL; Ragucci DP
    Pharmacotherapy; 2002 May; 22(5):645-8. PubMed ID: 12013365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.